Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US
Running, not enrolling · Phase 2 · Has a placebo group
Conditions studied: Overweight or Obesity
In brief
This study will test olatorepatide (study drug) to determine how safe and effective this drug is and how easily your body can accept this drug without causing side effects, as well as how the drug is processed in the body by participants with overweight or obesity. The study will test how safe and effective the study drug works compared to placebo in people who are overweight or obese but do not have diabetes. The study is looking at: * What side effects the study drug might cause * How much the study drug is in the blood at different times * How well the study drug works * If the body makes antibodies to the study drug as this may cause the study drug to not work as well
Key facts
- Study ID
- NCT07431086
- Run by
- Regeneron Pharmaceuticals
- People needed
- 120
- Starts
- 2026-03-16
- Expected to finish
- 2026-12-18
- Last updated by the study team
- 2026-06-17
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Diablo Clinical Research - Flourish Research — Walnut Creek, California, United States
- Clinical Site Partners, LLC DBA Flourish Research — Winter Park, Florida, United States
- Flourish Research - San Antonio Medical Trials — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.